Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -44.52 | N/A |
| PEG Ratio (TTM) | 0.49 | N/A |
| P/S Ratio (TTM) | 1.79 | N/A |
| P/B Ratio (TTM) | 1.30 | N/A |
| P/FCF Ratio (TTM) | -3.40 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.54% | N/A |
| ROE (TTM) | -3.07% | N/A |
| Net Profit Margin (TTM) | -3.77% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -33.91% | N/A | N/A |
| Revenue | 11.75% | N/A | N/A |
| Net Income | -33.23% | N/A | N/A |
| Cash Flow | 2.48% | N/A | N/A |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.24 | N/A |
| Quick Ratio (TTM) | 1.16 | N/A |
| D/E Ratio (TTM) | 0.63 | N/A |
| Interest Coverage (TTM) | 3.71 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.84 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |